Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100029, China.
Department of Cardiology, China-Japan Friendship Hospital, Beijing, 100029, China.
Cardiovasc Diabetol. 2023 Oct 21;22(1):284. doi: 10.1186/s12933-023-02011-2.
The Triglyceride-glucose (TyG) index, as a surrogate marker of insulin resistance, is independently associated with the severity of coronary artery lesions and the prognosis of coronary heart disease. The investigation aimed to explore the relationship between the TyG index and recurrent revascularization in individuals with type 2 diabetes mellitus (T2DM) resulting from the progression of lesions or in-stent restenosis (ISR) after percutaneous coronary intervention (PCI).
A total of 633 patients who met the inclusion and exclusion criteria were enrolled and divided into three groups based on the tertiles of the TyG index. The primary endpoint was recurrent revascularization resulting from the progression of lesions or ISR. All-cause death was considered as the competing risk event. Competing risk analysis and Cox regression analysis for predicting recurrent revascularization after PCI were conducted stepwise. Variables were standardized to make the hazard ratio (HR), subdistribution hazard ratio (SHR) and corresponding 95% CI more consistent prior to being used for fitting the multivariate risk model. The predictive ability of the TyG index was evaluated using several measures, including the ROC curve, likelihood ratio test, Akaike's information criteria, category-free continuous net reclassification improvement (cNRI > 0), and integrated discrimination improvement (IDI). Internal validation was conducted through bootstrapping with 1000 resamples.
During a median follow-up period of 18.33 months, a total of 64 (10.11%) patients experienced recurrent revascularization, including 55 cases of lesion progression and 9 cases of in-stent restenosis. After controlling for competitive risk events, the TyG index was independently associated with a higher risk of recurrent revascularization [SHR:1.4345, (95% CI 1.1458-1.7959), P = 0.002]. The likelihood ratio test and Akaike's information criteria showed that the TyG index significantly improves the prognostic ability. Additionally, adding the TyG index improved the ability of the established risk model in predicting recurrent revascularization, indicated by a C-index of 0.759 (95% CI 0.724-0.792, P < 0.01), with a cNRI > 0 of 0.170 (95% CI 0.023-0.287, P < 0.05), and an IDI of 0.024 (95% CI 0.009-0.039, P = 0.002). These results remained consistent when the models containing TyG index were confirmed using an internal bootstrap validation method.
The findings highlight the potential of the TyG index as a predictor of recurrent revascularization. Lesion progression emerged as the primary contributor to recurrent revascularization instead of in-stent restenosis. The incorporation of the TyG index into risk prediction models is likely to be beneficial for accurate risk stratification in order to improve prognosis.
三酰甘油-葡萄糖(TyG)指数作为胰岛素抵抗的替代标志物,与冠状动脉病变的严重程度和冠心病的预后独立相关。本研究旨在探讨 TyG 指数与 2 型糖尿病(T2DM)患者病变进展或经皮冠状动脉介入治疗(PCI)后支架内再狭窄(ISR)导致的再血管化之间的关系。
共纳入符合纳入和排除标准的 633 名患者,并根据 TyG 指数的三分位数将其分为三组。主要终点是由病变进展或 ISR 引起的再血管化。全因死亡被视为竞争风险事件。对 PCI 后再血管化的预测进行了逐步竞争风险分析和 Cox 回归分析。对变量进行了标准化,以便在拟合多变量风险模型之前使危险比(HR)、亚分布危险比(SHR)和相应的 95%CI 更加一致。使用 ROC 曲线、似然比检验、赤池信息量准则、无分类连续净重新分类改善(cNRI>0)和综合鉴别改善(IDI)等多个指标评估 TyG 指数的预测能力。内部验证通过 1000 次重采样的自举法进行。
在中位数为 18.33 个月的随访期间,共有 64 名(10.11%)患者发生再血管化,其中 55 例为病变进展,9 例为支架内再狭窄。在控制竞争风险事件后,TyG 指数与更高的再血管化风险独立相关[SHR:1.4345,(95%CI 1.1458-1.7959),P=0.002]。似然比检验和赤池信息量准则表明,TyG 指数显著提高了预后能力。此外,添加 TyG 指数可改善建立的风险模型预测再血管化的能力,表现在 C 指数为 0.759(95%CI 0.724-0.792,P<0.01),cNRI>0 为 0.170(95%CI 0.023-0.287,P<0.05),IDI 为 0.024(95%CI 0.009-0.039,P=0.002)。当使用内部自举验证方法确认包含 TyG 指数的模型时,这些结果仍然一致。
研究结果强调了 TyG 指数作为再血管化预测因子的潜力。病变进展是再血管化的主要原因,而不是支架内再狭窄。将 TyG 指数纳入风险预测模型可能有助于准确进行风险分层,从而改善预后。